Skip to main content

Table 1 Demographic characteristic regarding fibrosis degree (fibrosis versus cirrhosis) in non-diabetic and diabetic group

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable Liver fibrosis Significance Liver cirrhosis Significance
GI a no-diabetes
(n = 40)
GII a diabetic
(n = 40)
p value GI b no-diabetes
(n = 40)
GII b diabetic
(n = 40)
p value
Age (years)       
Mean ± SD
Range
39.45 ± 9.07
23–58
41.55 ± 7.57
24–57
0.26
(U test)
40.79 ± 11.65
20–64
57.58 ± 4.39
45–70
 < 0.001***
(U test)
BMI:
(Kg/m2)
      
Mean ± SD
Range
25.69 ± 2.42
22–34
27.57 ± 2.74
20–32
0.001***
(U test)
24.98 ± 3
20–31
25 ± 2
22–29
0.97
(U test)
Sex       
Male n (%) 22 (55%) 28 (70%) 0.58
(χ2 test)
32 (80%) 31 (77.5%) 0.78
(χ2 test)
Female n (%) 18 (45%) 12 (30%) 8 (20%) 9 (22.5%)
  1. ***Highly significant p < 0.001 U: Mann–Whitney test